Literature DB >> 35109711

Combined Inhibition of Fyn and c-Src Protects Hippocampal Neurons and Improves Spatial Memory via ROCK after Traumatic Brain Injury.

Zhouheng Ye1, Ali Izadi2, Gene G Gurkoff2, Kaitlin Rickerl1, Frank R Sharp1, Bradley P Ander1, Sawyer Z Bauer1, Austin Lui1, Bruce G Lyeth2, DaZhi Liu1.   

Abstract

Our previous studies demonstrated that traumatic brain injury (TBI) and ventricular administration of thrombin caused hippocampal neuron loss and cognitive dysfunction via activation of Src family kinases (SFKs). Based on SFK localization in brain, we hypothesized SFK subtypes Fyn and c-Src, as well as SFK downstream molecule Rho-associated protein kinase (ROCK), contribute to cell death and cognitive dysfunction after TBI. We administered nanoparticle wrapped small interfering RNA (siRNA)-Fyn and siRNA-c-Src, or ROCK inhibitor Y-27632 to adult rats subjected to moderate lateral fluid percussion (LFP)-induced TBI. Spatial memory function was assessed from 12 to 16 days, and NeuN stained hippocampal neurons were assessed 16 days after TBI. The combination of siRNA-Fyn and siRNA-c-Src, but neither alone, prevented hippocampal neuron loss and spatial memory deficits after TBI. The ROCK inhibitor Y-27632 also prevented hippocampal neuronal loss and spatial memory deficits after TBI. The data suggest that the combined actions of three kinases (Fyn, c-Src, ROCK) mediate hippocampal neuronal cell death and spatial memory deficits produced by LFP-TBI, and that inhibiting this pathway prevents the TBI-induced cell death and memory deficits.

Entities:  

Keywords:  Fyn; ROCK; c-Src; siRNA; traumatic brain injury

Mesh:

Substances:

Year:  2022        PMID: 35109711      PMCID: PMC8978569          DOI: 10.1089/neu.2021.0311

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  36 in total

Review 1.  The dual role of SRC kinases in intracerebral hemorrhage.

Authors:  Da-Zhi Liu; Frank R Sharp
Journal:  Acta Neurochir Suppl       Date:  2011

2.  Blood-brain barrier breakdown and repair by Src after thrombin-induced injury.

Authors:  Da-Zhi Liu; Bradley P Ander; Huichun Xu; Yan Shen; Pali Kaur; Wenbin Deng; Frank R Sharp
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

3.  Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors.

Authors:  Zhaoju Wu; Pei-Ching Chang; Joy C Yang; Cheng-Ying Chu; Ling-Yu Wang; Nien-Tsu Chen; Ai-Hong Ma; Sonal J Desai; Su Hao Lo; Christopher P Evans; Kit S Lam; Hsing-Jien Kung
Journal:  Genes Cancer       Date:  2010-01

4.  Activation of Rho after traumatic brain injury and seizure in rats.

Authors:  Catherine I Dubreuil; Niklas Marklund; Kathleen Deschamps; Tracy K McIntosh; Lisa McKerracher
Journal:  Exp Neurol       Date:  2006-01-31       Impact factor: 5.330

Review 5.  Rho/ROCK signaling in motility and metastasis of gastric cancer.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

6.  Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Authors:  Da-Zhi Liu; Xi-Yuan Cheng; Bradley P Ander; Huichun Xu; Ryan R Davis; Jeffrey P Gregg; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2008-02-09       Impact factor: 5.996

7.  Glutamate receptor blockade attenuates glucose hypermetabolism in perihematomal brain after experimental intracerebral hemorrhage in rat.

Authors:  Timothy D Ardizzone; Aigang Lu; Kenneth R Wagner; Yang Tang; Ruiqiong Ran; Frank R Sharp
Journal:  Stroke       Date:  2004-09-16       Impact factor: 7.914

8.  ROCK I-mediated activation of NF-kappaB by RhoB.

Authors:  Pedro L Rodriguez; Sutapa Sahay; Oyenike O Olabisi; Ian P Whitehead
Journal:  Cell Signal       Date:  2007-08-08       Impact factor: 4.315

9.  Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice.

Authors:  P L Stein; H Vogel; P Soriano
Journal:  Genes Dev       Date:  1994-09-01       Impact factor: 11.361

Review 10.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Authors:  Da-Zhi Liu; Bradley P Ander
Journal:  ScientificWorldJournal       Date:  2012-04-01
View more
  1 in total

1.  Brain-derived neurotrophic factor regulates LYN kinase-mediated myosin light chain kinase activation to modulate nonmuscle myosin II activity in hippocampal neurons.

Authors:  Xiaobing Li; Rong-Rong Yuan; Qixia Wang; Shouyu Chai; Zhengying Zhang; Yue Wang; Shu-Hong Huang
Journal:  J Biol Chem       Date:  2022-05-20       Impact factor: 5.486

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.